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Background: Fusobacterium nucleatum is a Gram-negative anaerobic bacterium associated
with periodontal disease. Some oral bacteria, like Porphyromonas gingivalis, evade the host
immune response by inhibiting inflammation. On the other hand, F. nucleatum triggers
inflammasome activation and release of danger-associated molecular patterns (DAMPs) in
infected gingival epithelial cells.
Methods: In this study, we characterized the pro-inflammatory response to F. nucleatum oral
infection in BALB/c mice. Western blots and ELISA were used to measure cytokine and
DAMP (HMGB1) levels in the oral cavity after infection. Histology and flow cytometry were
used to observe recruitment of immune cells to infected tissue and pathology.
Results: Our results show increased expression and production of pro-inflammatory cyto-
kines during infection. Furthermore, we observe that F. nucleatum infection leads to
recruitment of macrophages in different tissues of the oral cavity. Infection also contrib-
utes to osteoclast recruitment, which could be involved in the observed bone resorption.
Conclusions: Overall, our findings suggest that F. nucleatum infection rapidly induces
inflammation, release of DAMPs, and macrophage infiltration in gingival tissues and sug-
gest that osteoclasts may drive bone resorption at early stages of the inflammatory
process.edical Sciences, University of the Pacific, Arthur Dugoni School of Dentistry, 155 Fifth St.,
. Ojcius).
g Gung University.
p.
ublishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND
/by-nc-nd/4.0/).
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Scientific background on the subject
The effect of Fusobacterium nucleatum on the immune
response remains poorly understood inmousemodels of
oral infection.
What this study adds to the field
This study showed that oral infection with F. nucleatum
stimulates inflammation and infiltration of macro-
phages in gingival tissue, which could lead to bone loss
in the oral cavity.The oral cavity is colonized with hundreds of different
species of bacteria which compose the oral microbiome [1,2].
Some common bacteria found in individuals afflicted with
periodontitis include Fusobacterium nucleatum, Porphyromonas
gingivalis, and Aggregatibacter actinomycetemcomitans [3,4].
Gingivitis is diagnosed when the gingiva, or gums, reveals
signs of swelling, redness, or chronic bleeding [5], usually
associated with gingival infection. However, chronic inflam-
mation can lead to development of periodontitis with signs of
deep periodontal pockets, alveolar bone resorption, and tooth
loss [6,7].
The tooth is surrounded by the gingival epithelium. This
microenvironment is optimal for growth of anaerobic bacteria
and provides an opportunity for pathogenic bacteria to attach
and coaggregate into biofilms [8]. F. nucleatum is one of the
predominant bacteria and contributors to biofilm formation
[9e11]. Thebacteria utilize adhesionmechanisms of lectin-like
and non-lectin-like interactions and adhesion peptides, such
as FadA (Fusobacterium adhesin A) for attachment [12e16].
These interactions facilitate coaggregation or infiltration into
lymphocytes, polymorphonuclear neutrophils, erythrocytes,
epithelial cells, and fibroblasts [11,12,14,17,18].
The oral epithelium defends against bacterial colonization
by secretion of antimicrobial peptides called defensins
[4,19e21]. b-defensins target bacteria as the peptides are
electrostatically attracted to their negative charged mem-
branes and induce pore formation [4,19,22]. Antimicrobial
peptides can also act as chemoattractants and recruit other
immune cells, neutrophils or T cells [4,7,19]. Thus, b-defensins
play an active role as part of innate and adaptive responses to
oral infection.
Gingival epithelial cells (GECs) represent a major barrier to
infection by invasive bacteria, and also contribute to immune
recognition of the pathogens and the immune response
[23,24]. When pathogen-associated molecular patterns
(PAMPs) of bacteria are recognized by host pathogen recog-
nition receptors (PRRs) on GECs, they activate NF-kB and
induce expression of cytokines and chemokines, and recruit
neutrophils and macrophages [25e27]. Recognition of F.
nucleatum and A. actinomycetemcomitans infection results in
production of cytokines such as IL-1b [28e30]. TNF-a and IL-17
can also synergize with IL-1b to enhance expression and
production of other cytokines (e.g., IL-6) and defensins, alongwith endothelial activation to enhance the immune response
[31e36].
Although the goal of inflammation is to resolve oral
infection, it can also lead to bone resorption. Alveolar bone is
one of themost dynamic bones in the body, as osteoclasts and
osteoblasts continually induce bone remodeling to maintain
homeostasis [37e40]. Osteoclasts are resorptive cells that are
activated and differentiated by macrophage-colony stimu-
lating factor, receptor activator of nuclear factor kappa-B
ligand (RANKL)-RANK signaling, interleukins, and TNF-a
[38,39,41e43]. Once osteoclasts adhere to bone, a ruffled
border is created between the activated osteoclast and bone
[38,40], and osteoclasts are able to degrade the mineral matrix
[38,40]. Degraded bone matrix is removed as it is transcytosed
in vesicles through osteoclasts, and fuses with cytoplasmic
vesicles containing tartrate-resistant acid phosphatase (TRAP)
to be released in the extracellular matrix [38,44]. Phagocytes
remove the debris and osteoblasts are recruited for bone for-
mation after osteoclasts detach from the bone [38].
F. nucleatum mechanisms for invasion and host response
have been evaluated both in vitro and in vivo [3,45e48]. We
have previously reported that F. nucleatum infection induces
inflammasome activation and release of cytokines and danger
signals in human GECs in vitro [29,46]. In this study, we
examined the immune response to F. nucleatum oral infection
in BALB/c mice, which had not been previously characterized.Materials and methods
Bacteria
F. nucleatum (ATCC 25586) was cultured at 37 C under anaer-
obic conditions in brain-heart infusion broth supplemented
with yeast extract (5 mg/mL), hemin (5 mg/mL), and mena-
dione (1 mg/mL). Erythromycin (5 mg/ml) was used as a selec-
tive agent for F. nucleatum as previously described [49]. After
24 h of growth, bacteria were collected by centrifugation at
6000  g for 10 min at 4 C, washed twice and resuspended
with phosphate-buffered saline (PBS). Quantification of bac-
teria was measured by optical density (OD) to obtain a con-
centration of 109 colony-forming units (CFU)/ml using a
reference standard.
Mice and oral challenge with F. nucleatum
BALB/c mice were obtained from the animal facility of the
Institute of Biophysics Carlos Chagas Filho at the Federal
University of Rio de Janeiro. All protocols used in this study
followed the guidelines and were approved by the Institu-
tional Animal Care and Use Committee at the Federal Uni-
versity of Rio de Janeiro (CEUA-UFRJ 076/15).
Six-to eight-week-old male BALB/c mice were given ad
libitum water containing 10 mL of Bactrim (Roche) comprised
of sulfamethoxazole/trimethoprim for 10 days. Then
antibiotic-free water was given to the mice for 3 days prior to
infection. The protocol for oral infection was adapted from
Baker et al. [50]. On days of infection, mice were anesthetized
with 100 ml of ketamine-xylazine solution (100 mg/ml and
20 mg/ml) by intraperitoneal injection. Anesthetized mice
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100 ml of PBS with 2% carboxymethylcellulose (Sigma), or were
sham-infected with the same solution containing no bacteria
three times over 2-day intervals.
Collection of maxilla
Maxillas were surgically removed collected at days 1, 4, and 7
after the last infection day. Half maxilla was placed in TRIzol
reagent (Life Technologies) for PCR analysis and the other half
in cell lysis buffer (Sigma) containing protease inhibitor
(Roche) for western blotting analysis. Then the samples were
macerated and homogenized using TissueLyser LT (Qiagen)
for 5 min at 50 Hz. After centrifugation at 1000  g for 10 min
supernatants were transferred to new tubes and used for ex-
periments. Prior to protein assays, maxilla halves from each
group of mice were pooled together and quantified using
Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) for
equal loading.
Isolation, processing and analysis of murine gingival cells
The isolation, processing and analysis of murine maxilla
gingival cells collected from uninfected or F. nucleatum-infec-
ted mice was as described by Mizraji et al., 2013 [51]. Briefly,
after the protocol for oral infection,mice were euthanized and
both upper and lower mandibles were collected. The mandi-
bles were cut into hemi-maxillae and the palatal tissue was
trimmed until reaching the alveolar bone. Gingival tissues
were peeled using forceps (without teeth), placed in 1 ml
PBS þ 2% FCS, 2 mg/mL of collagenase type II and 1 mg/mL of
DNAse type1,wellmincedand incubated in a shaker incubator
for 20 min at 37 C, 200 rpm, plus an additional 10 min after
adding 20 ml of EDTA0.5M. Sampleswerewashedwith 12ml of
PBS þ 2% FCS and centrifuged at 4 C, 400  g for 8 min. Cells
were resuspended with 2 ml PBS þ 2% FCS and filtered on a
70 mm cell-strainer. The collected samples were centrifuged at
4 C, 320  g for 5 min and resuspended with 300 mL PBS þ 2%
FCS for cellular quantification and antibody staining.
Flow cytometry analysis
Freshly isolated murine gingival cells were immunostained
for flow cytometry analysis. 5  105 cells were stained with
0.1 mg/mL Fixable Viability Stain 510 (FVS510) e BD Horizon™
for 15 min at room temperature to distinguish live and dead
cells. After washing with PBS, cells were blocked for nonspe-
cific binding with 5 mg/mLwith CD16/32mAb for 20 min on ice
and stained with the following monoclonal antibodies (eBio-
science) for 30 min at 4 C: 1 mg/mL anti-CD90 (Thy-1.2) APC
(Clone 53e2.1), 1 mg/mL anti- F4/80 Antigen eFluor® 450 (Clone
BM8), 1 mg/mL anti-Ly-6G PE (clone 1A8-Ly6g), 2.5 mg/mL anti-
CD11b Alexa Fluor® 488 (Clone M1/70). Cells were washed
with PBS, fixed with 4% paraformaldehyde for 20 min at room
temperature and kept at PBS until their acquisition by flow
cytometry. Fluorescence was evaluated by acquiring 50,000
events/sample using FACSCanto II (BD Biosciences, San Jose,
California, USA). Results were analyzed using the FACSDiva
(BD Biosciences, San Jose, California, USA) and presented as
percentage of positive events.RNA extraction and quantitative PCR
Following the manufacturer's instructions, total RNA was
extracted using Trizol Reagent (Life Technologies). Total RNA
was quantified by using NanoDrop (Thermo Fisher Scientific).
RNAwas converted to cDNA using High-Capacity cDNA Reverse
Transcription Kit (Life Technologies). Quantitative PCR was
performed using SYBR-green fluorescence quantification sys-
tem (SYBR Select Master Mix (Life Technologies)). Real-time PCR
cycling parameterswere as follows: 95 C for 10min and then 40
cycles of 95 C for 30 s, 60 C for 1 min, and 72 C for 1 min. The
following primers were used as previously described: IL-1b for-
ward, 50-TTCAGGCAGGCAGTATCACTC-30; IL-1b reverse, 50-
CCACGGGAAAGACACAGGTAG-30; TNFa forward, 50-TTCTATG
GCCCAGACCCTCA-30; TNFa reverse, 50-GTGGTTTGCTACG
ACGTGGG-30; IL-6 forward, 50-TCCTCTCTGCAAGAGACTTCC-30;
IL-6 reverse, 50-TTGTGAAGTAGGGAAGGCCG-30; IL-17 forward,
50-TCAGCGTGTCCAAACACTGAG-30, IL-17 reverse, 50-GACTTT-
GAGGTTGACCTTCACAT-30; GAPDH forward, 50-GGTCATCCCA-
GAGCTGAACG-30; GAPDH reverse, 50- TTGCTGTTGAAG
TCGCAGGA-30 [52]. Relative expression levels were calculated
against GAPDH as the reference gene using the comparative
cycle threshold method. Quantification of infected mice results
were normalized against control mice.PCR
The PCR was performed following the protocol from Liu et al.
[53]. Maxilla RNA targeted a 360-bp region using F. nucleatum
forward, 50-AGAGTTTGATCCTGGCTCAG-30 and reverse, 50-
GTCATCGTGCACACAGAATTGCTG-30 primer sequences [53].
The samples were amplified using GoTaq Green Master Mix
(Promega) under the same conditions of 5 min at 94 C and 30
cycles, with each cycle consisting of denaturation at 94 C for
30 s, annealing at 58 C for 30 s, extension at 72 C for 1 min,
and final extension for 10min. PCR products were loaded onto
a 2% gel in Tris-acetate buffer with EDTA. The gel was stained
with GelRed nucleic acid gel stain (Biotium) and visualized
under UV light.ELISA
Homogenizedmaxilla were used for ELISA experiments. IL-1b,
IFN-g, and TNF-a cytokine levels were measured using Mouse
IL-1b, IFN-g, and TNF-a ELISA kits (R&D Systems). ELISAs were
performed following manufacturer's instructions.Western blot
Protein samples were dissolved in 6X Laemmli buffer and
boiled. Then they were run on SDS-PAGE gels and trans-
ferred to PVDF membranes. Membranes were blocked with
5% BSA and incubated with anti-HMGB1 (Abcam) overnight.
After primary incubation, the membranes were washed and
incubated with HRP conjugated anti-goat IgG antibody (Mil-
lipore). Finally, the membranes were developed with Lumi-
nata Forte (Millipore) substrate. Images were acquired using
ImageQuant LAS 4000 system and analyzed using NIH-
ImageJ.
Fig. 1 Gene expression is upregulated in the maxilla during F. nucleatum infection. (AeE) Relative IL-1b, IFN-g, TNF-a, IL-6, and
IL-17 mRNA gene expression compared with control was evaluated by real-time PCR (qPCR) from the maxilla of F. nucleatum
infected BALB/c mice. Days 1, 4, and 7 post-infection were tested. Results represent an average of three independent
experiments with at least 4 mice in each group per experiment. Error bars represent themean ± SD. (*< 0.05, **<0.01, Student's t-
test).
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For morphological studies mandibles were collected and were
immediately immersed in zinc-formaldehyde for fixation for
72 h. Next, tissues were decalcified in Morse's solution for 7
days. The complete decalcification of bones was manually
assessed. Tissues were then washed in water and dehydrated
crescent solutions of ethanol, clarified in xylene and
embedded in paraffin. Five-micrometer sections were cut and
stained with hematoxylin-eosin (H&E). For immunohisto-
chemistry, paraffin sections were collected onto charged his-
tological slides. A ratmonoclonal antibody F4/80 (Abd Serotec)
was used to detect macrophages. Briefly, after dewaxing and
rehydrating, sections were submitted to endogenous peroxi-
dase inhibition (15 min with 3% H2O2 in methanol), followed
by an enzymatic antigen retrieval, with a 0.1% trypsin solution
containing 0.01% calcium chloride in Tris-buffer pH 7.4
(Sigma-Aldrich) for 5 min. After blocking nonspecific binding
of immunoglobulins, primary antibody was incubated for
14e18 h, at 4 C, in a humid chamber. The sections were then
washed in 0.25% Tween-phosphate saline buffer (PBS) solu-
tion for 5 min and then the secondary antibody conjugated to
peroxidase were incubated for 1 h at room temperature
(Nichirei). The chromogen substrate was diaminobenzidine
(Dako). Negative control slides were incubated with rat
nonimmune serum or with the antibody diluent solution.Histomorphometry
Histomorphometry was performed using a computer-assisted
image analysis system comprising a Nikon Eclipse E-800 mi-
croscope connected via a digital camera (Evolution, Media
Cybernetics Inc., Bethesda, MD) to a computer. The graphical
interface software Q-Capture 2.95.0, version 2.0.5 (Silicon
Graphic Inc., Milpitas, CA) was used. Ten high quality photo-
micrographs (high-quality images, 2048  1536 pixel buffer)
were randomly captured from tissues of each animal using
the 40 objective lens.Quantification of the number of F4/80 macrophages
The number of macrophages was quantified in F4/80-stained
sections. Results were expressed as the number of macro-
phages/histological field.AFM force spectroscopy
For force spectroscopy studies, uninfected and 1, 4 and 7 days
infected mandibles were collected and immediately
immersed in PBS. After, tissues were cleaned, and the region
of alveolar bone was exposed to start the measurement. Bone
region was examined in a Dimension Icon Scanning Probe
Microscopy (Bruker, Santa Barbara e CA). RTESPA-300 AFM
probe (Bruker, Camarillo e CA) was used and its cantilever
elastic constant was obtained by thermal noise method. Force
curves were acquired in air using contact mode and young
modulus elasticity was extracted by those curves using
NanoScope Analysis 1.5 software (Bruker, Santa Barbara e
CA).
Statistical analysis
Results are shown as mean ± standard deviation (SD). Statis-
tical significance was calculated by two-tailed Student's t-test
and differences were considered significant at P < 0.05.
SPM results were evaluated by one-way Anova followed by
Dunnett's test and differences were considered significant at
p < 0.05.Results
F. nucleatum infection induced pro-inflammatory cytokine
expression in maxilla
To assess cytokine expression in F. nucleatum-infected mice, we
isolated RNA from the maxilla at various time points post-
infection. Since F. nucleatum infection in GECs led to a time-
dependent increase of IL-1b gene expression in vitro [46], we
determinedwhether oral infection of F. nucleatum inmicewould
similarly upregulate IL-1b gene expression over a course of
7 d.p.i. (days post infection) [Fig. 1A]. Indeed, we observed a sig-
nificant induction of IL-1b 1 d.p.i. compared to uninfected mice
followed by a decrease in the transcriptional response there-
after. Because it was already known that F. nucleatum-infected
BMDMs trigger cytokineproduction (suchas IL-1b, TNF-a, and IL-
6) through the Toll-like receptor (TLR) signaling pathway [54], we
analyzed mRNA expression of other pro-inflammatory cyto-
kines in our in vivomodel of F. nucleatum infection. IFN-g and IL-6
mRNA expression followed the same time-dependent response
Fig. 2 F. nucleatum infection induces increased cytokine production in the maxilla. (AeC) The cytokines IL-1b, IFN-g, and TNF-a
were measured by ELISA. Maxilla from days 1, 4, and 7 post-infection with F. nucleatum were evaluated. (D) Western blotting to
evaluate immature pro-IL-1b (33 kDa) and mature IL-1b (17 kDa) protein expression from the maxilla of F. nucleatum-infected
BALB/c mice at day 4. Actin (42 kDa) was used as a loading control. (E) Relative protein was measured by quantification of
densitometry using NIH-ImageJ. (AeC) represent an average of three independent experiments with at least 4 mice in each
group per experiment. (D and E) represent average of 4 mice in each group. Error bars represent the mean ± SD. (*< 0.05, **<0.01,
Student's t-test).
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decreasing thereafter [Fig. 1B and D]. On the other hand, TNF-a
enhancementwasdelayed (at 4d.p.i) butalsodeclined thereafter
[Fig. 1C]. Since IL-17 is implicated in bone resorption [52e55], we
examine its transcriptional response and found that it was
upregulated early during infection, at 1 d.p.i., as observed for IL-
1b, IFN-g and IL-6 [Fig. 1E]. The results indicated that multiple
pro-inflammatory cytokineswereupregulatedduring the course
of F. nucleatum infection.
Cytokine production is enhanced in the maxilla during F.
nucleatum infection
To directly evaluate cytokine production, we performed ELISA
analysis using maxilla samples of infected mice and found
that IL-1b and IFN-g levels increased at 4 d.p.i.; i.e., 3 d after the
transcriptional activation of these genes [Fig. 2A and B].
Additionally, a slight (non-statistically significant) increase of
TNF-a was noted at 4 d pi [Fig. 2C].
To further analyze the cytokine production, we determined
byWestern blotting the presence of the immature andmature
forms of IL-1b in the maxilla of mice at the peak of cytokine
production (4 d.p.i.). There was an enhancement of pro-IL-1b
and IL-1b protein expression in the maxilla of F. nucleatum-
infected mice, compared with sham-infected mice [Fig. 2D].
Confirmed by densitometry analysis [Fig. 2E], these datasuggest that the early (1 d.p.i.) transcriptional response
induced by F. nucleatum translated into sustained production
of the pro-IL-1b precursor, which underwent cleavage at this
time-point (4 d.p.i.). These in vivo results are consistent with
our previous findings showing that IL-1b production by F.
nucleatum-infected GECs is driven by the NRLP3
inflammasome-caspase 1 pathway [29].
Next, we looked at high mobility group box 1 (HMGB1)
expression because this damage-associated motif pattern
(DAMP) acts as a transcription regulator, pro-inflammatory
cytokine, and macrophage activator [55e57]. IFN-g, TNF-a,
and TGF-b have been shown to augment expression of HMGB1
mRNA in THP-1 macrophages and human peripheral-blood
monocytes [56,58]. As we observed an increase in two of
these cytokines during F. nucleatum oral infection, it seemed
plausible that these pro-inflammatory responses were linked
to HMGB1 production. Using Western blot analysis, we found
a significant increase of HMGB1 expression at 4 d.p.i. as
compared with the sham-infected mice [Fig. 3A and B].
F. nucleatum infection results in recruitment of immune
cells to the maxilla
Given that inflammatory cytokine production is increased
over time in F. nucleatum infected mice, we next characterized
the dynamics of leukocyte infiltration in tissue sections
Fig. 3 HMGB1 levels augmented at day 4 post-infection. (A)
HMGB1 (25 kDa) was detected by Western blot from the
maxilla of BALB/c mice infected with F. nucleatum over a
time-course of day 1, 4, and 7 post-infection. Actin (42 kDa)
was used as a loading control. (B) Relative protein was
measured by quantification of densitometry using NIH-
ImageJ. Results represent an average of three independent
experiments with at least 4 mice in each group per
experiment. Error bars represent the mean ± SD. (*< 0.05
Student's t-test).
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increased numbers of infiltrating leukocytes near the alveolar
bone at 1, 4 and 7 d.p.i., when compared with uninfectedmice
[Fig. 4A]. To confirm this result, we quantified total inflam-
matory cells isolated from murine gingival tissues surround-
ing the teeth and found increased infiltration at 4 d.p.i. as
compared with the uninfected group [Fig. 4B].
To further characterize the infiltrated cells after F. nuclea-
tum infection in vivo, we used immunohistochemistry images
to observe macrophage infiltration of the infected gingival
tissues. F4/80þ staining revealed that macrophage recruit-
ment is increased in the infected gingiva (1 and 7 d.p.i.) when
compared with uninfected mice [Fig. 5A and B]. We next
quantified CD11bþ Ly6Gþ neutrophils [Fig. 5C] and
CD90 þ lymphocytes [Fig. 5D] and found a modest increase
(not statistically significant) in both subsets in the infected
mice group compared to controls [59]. Activated macrophages
were detected in adipose tissues, skeletal muscle fibers, and
periosteal localization [59]. Noteworthy, however, macro-
phagesweremore concentrated in the dental pulp, around the
periodontal ligaments, and also between odontoblasts.Bone resorption during F. nucleatum infection
Osteoclast activation leads to their attachment to the bone,
resorption of the bone through its secretory factors, and
detachment from the resorption site [60,61]. Previous studies
have shown that IL-1b, and TNF-a enhance osteoclast devel-
opment [41,62,63]. Since the production of these cytokines
was elevated during F. nucleatum infection, we determined
whether these inflammatory responses were coupled to bone
resorption by osteoclasts. Indeed, we detected bone resorp-
tion pits in the alveolar bone (7 d.p.i.) compared to the unin-
fected group [Fig. 6], which may have resulted from osteoclast
involvement.
F. nucleatum infection is associated with softened alveolar
bone
To analyze the impact of the infection on bone structure, we
measured the mechanical properties of the alveolar bone by
Force Spectroscopy using an atomic force microscope. Unin-
fected mice prepared for these experiments expressed an
elastic constant average of 7.95 ± 10.73 GPa [Fig. 7]. Infected
mice had a significantly lower elasticity when compared with
uninfected mice. These differences were more obvious be-
tween uninfected and infected mice 1 d.p.i, when elasticity
decreased to 2.76 ± 5.56 GPa. Elasticity values at days 4 and 7
were 5.61 ± 7.88 GPa and 3.44 ± 3.42 GPa, respectively [Fig. 7].Discussion
Previous studies have examined the mechanisms involved in
the adhesion and metabolic growth interactions between F.
nucleatum and other periodontal bacteria, such as P. gingivalis
and A. actinomycetemcomitans [64e67], but monomicrobial oral
infection with F. nucleatum in BALB/c mice had never been
reported.
Our studies demonstrated that F. nucleatum can rapidly
trigger inflammatory responses, manifested as increased
mRNA for pro-inflammatory cytokines such as IL-1b, IFN-g, IL-
6 and IL-17 at 1 d.p.i., and secreted high levels of IL-1b and IFN-
g and the DAMP, HMGB1, in themaxilla at 4 d.p.i. These effects
were followed by immune cell infiltration in gingival tissue
observed from 1 d.p.i. on, culminating in bone resorption
detected as early as 7 d.p.i. Alveolar bone softness was
detected soon after, at 1 d.p.i.
Different oral bacteria can negatively or positively regulate
the production of pro-inflammatory cytokines in GECs. While
P. gingivalis subverts innate immunity by dampening IL-1b and
HMGB1 release during infection in GECs, A. actino-
mycetemcomitans can stimulate IL-6 and TNF-a production in
BMDMs [54,68]. Likewise, infection with F. nucleatum stimu-
lates cytokine production through the activation of Toll-like
receptor (TLR)-2 and TLR-4 [54,69,70], or alternatively,
through TLR-independent pathways [70,71]. Our results show
that F. nucleatum-infected mice upregulate IL-1b, IL-6, TNF-a,
and HMGB1, consistent with previous in vitro studies on GECs
and BMDMs infected with F. nucleatum [46,54].
Given the heightened inflammatory response induced by F.
nucleatum infection, it was not surprising to see a recruitment
Fig. 4 Immune cells are recruited near the alveolar bone during F. nucleatum infection. (A) Sections from mandible of infected
BALB/c mice were stained with H&E. Arrows indicate area of immune cells localized near the bone in dark stain. Bar represents
100 mm. (B) Total immune cells recruited to the murine gingival tissue of F. nucleatum-infected BALB/c mice at day 4. Graph
shows mean ± SD of immune cell numbers found in the murine gingival tissue of infected mice. Results show an average of 6
mice in each group (**<0.01, Student's t-test).
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rophages are known to reside in dental pulp [72]. Their acti-
vation relies on exposure to IFN-g, TNF-a, and LPS [73e75].
IFN-g is important for antibacterial activity and is augmented
by stimulation with LPS [76e78]. We found that F. nucleatumFig. 5 F. nucleatum infection increases immune cell recruitment i
Immunohistochemistry for F4/80þ macrophages in the dental pu
Quantification of macrophages from 10 histological fields. Total (
recruited to the murine gingival tissue of F. nucleatum-infected BA
cells numbers found in the murine gingival tissue of infected or un
group. Error bars represent the mean ± SD. (*<0.05, ***<0.001, Stuinfection induced significant levels of IFN-g. In addition,
immunohistochemistry revealed the recruitment of macro-
phages throughout the oral cavity.
It remains to be determined whether IFN-g promotes or
inhibits osteoclast activation [39,62,79,80]. However, in ourn the dental pulp and in gingival tissue. (A)
lp of infected BALB/c mice. Bar represents 50 mm. (B)
C) neutrophils (CD11bþ Ly6Gþ) and (D) lymphocytes (CD90þ)
LB/c mice at day 4. Graphs show the mean ± SD of immune
infectedmice. (C and D) each point represents 2 mice in each
dent's t-test).
Fig. 6 F. nucleatum infection induces bone resorption. Mandibles of infected BALB/c mice were stained with H&E. Arrows
indicate areas of bone resorption. Bar represents 50 mm.
Fig. 7 Alveolar bone is more elastic in F. nucleatum-infected
mice. Young modulus of alveolar bone was measured with
an atomic force microscope. Results represent an average of
at least 160 measurements from 4 different mice per group.
Error bars represent the mean ± SD. Multiple comparisons
were corrected with Dunnett's method.
b i om e d i c a l j o u r n a l 4 1 ( 2 0 1 8 ) 1 8 4e1 9 3 191study, IFN-gmay have contributed to activation of osteoclasts
as they were observed localized near the bone after F. nuclea-
tum infection. Moreover, TNF-a and IL-17 synergize with IL-1b,
and can facilitate osteoclast activation, further supporting a
role for these cytokines in bone loss in the mandible [81,82]
during infection with F. nucleatum.Conflicts of interest
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